1. Home
  2. RLYB vs KULR Comparison

RLYB vs KULR Comparison

Compare RLYB & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • KULR
  • Stock Information
  • Founded
  • RLYB 2018
  • KULR 2013
  • Country
  • RLYB United States
  • KULR United States
  • Employees
  • RLYB N/A
  • KULR N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • RLYB Health Care
  • KULR Technology
  • Exchange
  • RLYB Nasdaq
  • KULR Nasdaq
  • Market Cap
  • RLYB 45.6M
  • KULR 55.3M
  • IPO Year
  • RLYB 2021
  • KULR N/A
  • Fundamental
  • Price
  • RLYB $1.09
  • KULR $0.31
  • Analyst Decision
  • RLYB Buy
  • KULR Buy
  • Analyst Count
  • RLYB 6
  • KULR 1
  • Target Price
  • RLYB $8.30
  • KULR $1.00
  • AVG Volume (30 Days)
  • RLYB 50.8K
  • KULR 2.2M
  • Earning Date
  • RLYB 11-07-2024
  • KULR 11-12-2024
  • Dividend Yield
  • RLYB N/A
  • KULR N/A
  • EPS Growth
  • RLYB N/A
  • KULR N/A
  • EPS
  • RLYB N/A
  • KULR N/A
  • Revenue
  • RLYB $299,000.00
  • KULR $9,555,967.00
  • Revenue This Year
  • RLYB N/A
  • KULR N/A
  • Revenue Next Year
  • RLYB N/A
  • KULR $99.14
  • P/E Ratio
  • RLYB N/A
  • KULR N/A
  • Revenue Growth
  • RLYB N/A
  • KULR 24.72
  • 52 Week Low
  • RLYB $1.08
  • KULR $0.10
  • 52 Week High
  • RLYB $4.60
  • KULR $0.90
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 45.55
  • KULR 57.57
  • Support Level
  • RLYB $1.08
  • KULR $0.27
  • Resistance Level
  • RLYB $1.18
  • KULR $0.34
  • Average True Range (ATR)
  • RLYB 0.04
  • KULR 0.02
  • MACD
  • RLYB 0.00
  • KULR 0.00
  • Stochastic Oscillator
  • RLYB 15.00
  • KULR 57.43

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

Share on Social Networks: